Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Edaravone Dexborneol Concentrated Solution For Injection

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT05249920Phase 3Completed

Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2)

Showing all 1 trials

Research Network

Common Treatments

  • Edaravone Dexborneol Concentrated Solution For Injection1
  • Edaravone Dexborneol Placebo1

Active Sponsors

  • Beijing Tiantan Hospital1

Top Investigators

Related Conditions

  • Phase Iii1
  • Mechanical Thrombectomy1
  • Acute Ischemic Stroke1

Activity Timeline